Atypical Anti-psychotics (long-acting injectable) - Index

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

  • Revision history
    • Oct. 13, 2023
    • Oct. 22, 2021
    • Sept. 2019
  • Initially developed
    • Sept. 2017